Gsa Capital Partners LLP Cerus Corp Transaction History

Gsa Capital Partners LLP

$1.35 Billion
Q4 2024

A detailed history of Gsa Capital Partners LLP transactions in Cerus Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 1,328,456 shares of CERS stock, worth $2.03 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,328,456

Previous 959,978 38.38%

Holding current value

$2.03 Million

Previous $1.67 Million 22.51%

% of portfolio

0.15%

Previous 0.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$1.52 - $2.03 $560,086 - $748,010	368,478 Added 38.38%	1,328,456 $2.05 Million
Q3 2024 Nov 05, 2024	SELL	$1.7 - $2.39 $858,574 - $1.21 Million	-505,044 Reduced 34.47%	959,978 $1.67 Million
Q2 2024 Aug 15, 2024	BUY	$1.62 - $2.04 $985,787 - $1.24 Million	608,511 Added 71.05%	1,465,022 $2.58 Million
Q1 2024 May 03, 2024	SELL	$1.66 - $2.42 $244,582 - $356,560	-147,339 Reduced 14.68%	856,511 $1.62 Million
Q4 2023 Feb 16, 2024	SELL	$1.25 - $2.35 $360,253 - $677,277	-288,203 Reduced 22.31%	1,003,850 $2.17 Million
Q3 2023 Nov 15, 2023	BUY	$1.5 - $3.07 $1.84 Million - $3.77 Million	1,226,757 Added 1878.76%	1,292,053 $2.09 Million
Q2 2023 Aug 14, 2023	BUY	$1.79 - $2.9 $116,879 - $189,358	65,296 New	65,296 $160,000
Q4 2022 Feb 13, 2023	BUY	$3.38 - $4.22 $575,671 - $718,737	170,317 New	170,317 $622,000
Q2 2022 Aug 09, 2022	BUY	$4.41 - $5.69 $38,737 - $49,980	8,784 Added 37.11%	32,456 $172,000
Q1 2022 May 11, 2022	SELL	$4.81 - $6.99 $664,539 - $965,724	-138,158 Reduced 85.37%	23,672 $130,000
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $432,544 - $574,552	72,453 Added 81.06%	161,830 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$4.79 - $6.68 $139,336 - $194,314	29,089 Added 48.25%	89,377 $544,000
Q2 2021 Aug 05, 2021	SELL	$5.35 - $6.35 $976,155 - $1.16 Million	-182,459 Reduced 75.16%	60,288 $356,000
Q1 2021 May 10, 2021	BUY	$5.68 - $7.87 $1.28 Million - $1.77 Million	225,146 Added 1279.17%	242,747 $1.46 Million
Q4 2020 Feb 03, 2021	SELL	$5.25 - $8.56 $299,097 - $487,671	-56,971 Reduced 76.4%	17,601 $122,000
Q3 2020 Nov 06, 2020	BUY	$5.78 - $7.47 $431,026 - $557,052	74,572 New	74,572 $467,000
Q3 2019 Nov 12, 2019	SELL	$4.86 - $6.05 $113,767 - $141,624	-23,409 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$4.51 - $6.6 $47,652 - $69,735	10,566 Added 82.27%	23,409 $132,000
Q1 2019 May 15, 2019	SELL	$5.16 - $6.85 $91,971 - $122,094	-17,824 Reduced 58.12%	12,843 $80,000
Q4 2018 Feb 12, 2019	SELL	$4.89 - $7.16 $62,885 - $92,077	-12,860 Reduced 29.54%	30,667 $155,000
Q3 2018 Nov 13, 2018	SELL	$6.89 - $7.78 $960,466 - $1.08 Million	-139,400 Reduced 76.21%	43,527 $314,000
Q2 2018 Aug 09, 2018	BUY	$5.19 - $7.25 $949,391 - $1.33 Million	182,927 New	182,927 $1.22 Million

Others Institutions Holding CERS

# of Institutions

160

Shares Held

146M

Call Options Held

48.6K

Put Options Held

8.7K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $271M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Cerus Corp Transaction History